ESR9: Development of nanoliposomes, PLGA and SLNPs with improved capacity and stability to obtain the best pharmacokinetics and immune response for the cancer vaccines.

Summary
ESR9 Development of nanoliposomes PLGA and SLNPs with improved capacity and stability to obtain the best pharmacokinetics and immune response for the cancer vaccines
More information & hyperlinks
Web resources: https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5d7f2ea0b&appId=PPGMS
Search
Search on Google
Search on Bing
Search on DuckDuckGo
Associated projects
Organisations
  • Not specified
Powered by Chris Decubber BV